ESR1 and breast carcinoma: In breast cancer, phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase (PAICS), a bifunctional enzyme in DNPS, modulates the activity of estrogen receptor α (Erα) and confers tamoxifen resistance upon breast cancer cells [21].